Effect of amphotericin B on the lipids of yeast cells of Sporothrix schenckii

Mycopathologia

Volumn 136, Issue 3, 1996, Pages 125-131

  Hamdan, Júnia Soares ^a   Casali, Agnes Kiesling ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Amphotericin B; Lipids; Sporothrix schenckii; Sterols

Indexed keywords

SPOROTHRIX SCHENCKII;

EID: 0030403158     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00438917     Document Type: Article

References (40)

1. Rippon JW. Sporotrichosis, In: Rippon JW, ed. Medical Mycology. The pathogenic fungi and the pathogenic actinomycetes. Philadelphia: W.B. Saunders Company, 1988: 325-52.
2. Kwon-Chung KJ, Bennett JE. Sporotrichosis. In: Kwon-Chung KJ, Bennett, JE, eds. Medical Mycology. Philadelphia: Lea & Febiger, 1992: 707-29.
3. Schell WA, Pasarell L, Salkin IF, McGinnis MR. Bipolaris, Exophiala, Scedosporium, Sporothrix and other dematiaceous fungi. In: Murray PR, Baron EJ, Pfeiler MA, Tenover FC, Yolken RH, eds. Manual of Clinical Microbiology. Washington: ASM Press, 1995: 825-46.
4. Carlos IZ, Sgarbi DB, Angluster J, Alviano CS, Suva CL. Detection of cellular immunity with the soluble antigen of the fungus Sporothrix schenckii in the systemic form of the disease. Mycopathologia 1992; 117: 139-44.
5. Costa EO, Diniz LS, Fava-Netto C, Arruda C, Dagli ML. Epidemiological study of sporotrichosis and histoplasmosis in captive Latin American wild mammals, São Paulo Brazil. Mycopathologia 1994; 125: 19-22.
6. Aronson NE. Disseminated sporotrichosis. J Am Med Assoc 1992; 268: 2021.
7. Odom RB. Common superficial fungal infections in immuno-suppressed patients. J Am Acad Derm 1994; 31: 56-59.
8. Perfect JR. Role of classic dimorphic pathogens in contemporary mycosis. Infect Dis Clin Pract 1994; 3: 68-77.
9. Mercurio MG, Elewski BE. Therapy of sporotrichosis. Semin Dermatol 1993; 12: 285-89.
10. Restrepo A. Treatment of tropical mycosis. J Am Acad Dermatol 1994; 31: 91-102.
11. Kauffman CA. Newer developments in therapy for endemic mycosis. Clin Infect Dis 1994; 19: 28-32.
12. Medoff G, Dismukes WE, Pappagianis D, Diamond R, Gallis HA, Drutz D. Evaluation of new antifungal drugs for the treatment of systemic fungal infections. Clin Infect Dis 1992; 15: 274-81.
13. Diaz M, Negroni R, Montero-Gei F, Castro LGM, Sampaio SAP, Borelli D, Restrepo A, Franco L, Bran JL, Arathoon EG, Stevens DA. A Pan-American 5-year study of fluconazole therapy for deep mycosis in the immunocompetent host. Clin Infect Dis 1992; 14:68-72.
14. Bolao F, Podzamczer D, Ventin M, Gudiol F. Efficacy of acute phase and maintenance therapy with itraconazole in an AIDS patient with sporotrichosis. Eur J Clin Microbiol Infect Dis 1994; 13: 609-612.
15. Franzot SP, Hamdan JS. Effect of amphotericin B on the lipids of five different strains of Cryptococcus neoformans. Mycopathologia 1994; 128: 85-89.
16. Franzot, SP, Hamdan JS. Effects of three azole derivatives on the lipids of different strains of Cryptococcus neoformans. Mycoses 1995; 38:183-89.
17. Georgopapadakou NH, Dix BA, Smith SA, Freundeberger J, Funke PT. Effect of antifungal agents on lipid biosynthesis and membrane integrity in Candida albicans. Antimicrob Agents Chemother 1987; 31: 46-51
18. Gomes MRH, Resende MA. Fonsecaea pedrosoi: lipid composition and susceptibility to amphotericin B. Can J Microbiol 1992; 38: 209-14.
19. Hamdan JS, Resende MA. Lipid composition and effect of amphotericin B on yeast cells of Paracoccidioides brasiliensis. Mycopathologia 1988; 102: 97-105.
20. Pfaller MA, Riley J. Effects of fluconazole on the sterol and carbohydrate composition of four species of Candida. Eur J Clin Microbiol Infect Dis 1992; 11: 152-56.
21. Ghannoum MA, Spellberg BJ, Ibrahim AS, Ritchie JA, Currie B, Spitzer ED, Edwards JE, Casadevall A. Sterol composition of Cryptococcus neoformans in the presence and absence of fluconazole. Antimicrob Agents Chemother 1994; 38: 2029-33.
22. Brajtburg J, Powderly WG, Kobayashi GS, Medoff G. Amphotericin B: current understanding of mechanisms of action. Antimicrob Agents Chemother 1990; 34: 183-88.
23. Warnock DW. Amphotericin B: an introduction. J Antimicrob Chemother 1991; 28: 27-38.
24. Maeda M, Kitajima Y, Mori S. Speculative cell cycle in yeast-phase growth of Sporothrix schenckii: plasma membrane structure as revealed by freeze-fracture electron microscopy. Can J Microbiol 1988; 34: 1083-89.
25. Restrepo AM, Jimenez BE. Growth of Paracoccidioides brasiliensis yeast phase on chemically defined culture medium. J Clin Microbiol 1980; 12: 279-81.
26. Shadomy S, Espinel-Ingroff A, Cartwright RY. Estudios de laboratorio con agents antifungicos: pruebas de susceptibilidad y bioensayos. In: Lennette EH, Balows A, Hausler WJ, Shadomy HJ, eds. Manual de Microbiologia Clinica. Buenos Aires: Editorial Medica Panamericana, 1987: 1229-38.
27. Pfaller MA, Burmeister L, Bartlett MS, Rinaldi MG. Multicenter evaluation of four methods of yeast inoculum preparation. J Clin Microbiol 1988; 26: 1437-41.
28. Espinel-Ingroff A, Kerkering TM, Goldson PR, Shadomy S. Comparison study of broth macrodilution and microdilution antifungal susceptibility tests. J Clin Microbiol 1991; 29: 1089-94.
29. Letters R. Phospholipids of yeasts. In: Mills AE, ed. Aspects of Yeast Metabolism. Oxford: Blackwell, 1968: 303-19.
30. Hunter K, Rose AH. Lipid composition of Saccharomyces cerevisiae as influenced by growth temperatures. Biochim Biophys Acta 1973; 260: 639-53.
31. Breivick ON, Owades JL. Spectrophotometric semimicrode-termination of ergosterol in yeast. J Agric Food Chem 1957; 5: 360-3.
32. Moore PR, Baumann CA. Skin sterols, I: Colorimetric determination of cholesterol and other sterols in skin. J. Biol Chem 1952; 195: 615-21.
33. Kim SJ, Kwon-Chung KJ. Polyene-resistant mutants of Aspergillus fennelliae: sterol content and genetics. Antimicrob Agents Chemother 1974; 6: 102-13.
34. Meyer RD. Current role of therapy with amphotericin B. Clin Infect Dis 1992; 14: 154-160.
35. Rex JH, Pfaller MA, Rinaldi MG, Polak A, Galgiani JN. Anti-fungal susceptibility testing. Clin Microbiol Rev 1993; 6: 367-81.
36. Galgiani JN. Susceptibility testing of fungi: current status of the standardization process. Antimicrob Agents Chemother 1993; 37: 2717-21.
37. Hamdan JS, Resende MA, Cunha Jr AL, Alves CH, Cisalpino EO. Partial biochemical characterization of five Paracoccidioides brasiliensis strains. Curr Microbiol 1993; 27: 91-5.
38. Rattray IBM, Schibeci A, Kidby DK. Lipids of yeasts. Bacteriol Rev 1975; 39: 197-231.
39. Mishra P, Prasad R. An overview of lipids of Candida albicans. Prog Lipid Res 1990; 29: 65-85.
40. Mysyakina IS, Funtikova NS. Lipid composition of the Mucor INMI fungus in nystatin-decreased growth conditions. Microbiology Engl Tr 1991; 60: 443-8.